TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers?

By AZIZI M.   NICOLET L.   CHATELLIER G.   GUYENE T. T.   HEMPENIUS J.   MÉNARD J.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 53-53

Informa Healthcare

Access to resources Recommend Favorite

Renoprotective Effect of Calcium Channel Blockers in Combination with an Angiotensin Receptor Blocker in Elderly Patients with Hypertension. A Randomized Crossover Trial Between Benidipine and Amlodipine

By Miyagawa Koichi   Dohi Yasuaki   Nakazawa Ai   Sugiura Tomonori   Yamashita Sumiyo   Sato Koichi   Kimura Genjiro  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil

By UNGER THOMAS  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 14-18

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin‐receptor blockers and diuretics—Advantages of combination

By Mimran A.   Weir M. R.  

Blood Pressure, Vol. 14, Iss. 1, 2005-03 ,pp. : 6-11

Informa Healthcare

Access to resources Recommend Favorite